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Background:  Erythromelalgia is characterized 
by temperature-dependent redness, pain, and 
warmth in one or more extremities. It may be a pri-
mary disease, or it may occur secondarily because 
of underlying illness. It is a chronic, debilitating 
condition often resistant to medical treatment.
Purpose:  The present report evaluates massage 
as a complementary therapy to reduce pain and 
other symptoms associated with erythromelalgia.
Participant: A 31-year-old female with a long-
standing history of erythromelalgia bilaterally in 
the lower extremities presented with complaints of 
acute pain exacerbation, anxiety, decreased qual-
ity of sleep, and difficulty with activities of daily 
living for prolonged periods of time. She had no 
previous experience with massage therapy or any 
other complementary therapies.
Intervention:  Massage therapy was introduced 
over the course of 9 treatments, each 1 hour in du-
ration, using various massage therapy techniques, 
remedial exercise, and recommended home care.
Results:  In this patient with erythromelalgia, 
effleurage and petrissage as massage therapy tech-
niques provided temporary pain relief in the lower 
extremities and long-term benefits that relieved 
anxiety, which improved restorative sleep and 
increased the patient’s participation in activities 
of daily living.
Conclusions:  For this treatment protocol, thera-
pist observation and patient feedback suggest that 
massage therapy may lead to a state of increased 
relaxation, decreased stress, decreased muscle 
tension, and improved sleep. These positive effects 
may have an indirect role in the ability of the pa-
tient to cope with erythromelalgia day to day.
KEYWORDS: Erythromelalgia, massage therapy, 
pain management
INTRODUCTION
Erythromelalgia is characterized by temperature-
dependent redness, pain, and warmth in one or more 
extremities. It may be a primary disease, or it may 
occur secondarily to an underlying illness(1). Primary 
erythromelalgia is caused by mutation of the voltage-
gated sodium channel α-subunit gene SCN9A(2). 
Primary erythromelalgia may be classified as either 
familial or sporadic, with the familial form inher-
ited in an autosomal dominant manner. Secondary 
erythromelalgia can result from small-fiber periph-
eral neuropathy attributable to hypercholesterolemia, 
mushroom or mercury poisoning, or an autoimmune 
disorder(3). Erythromelalgia interferes with daily liv-
ing and ability to work, because diagnosed patients 
experience a high degree of pain. This interference 
can lead to increased isolation, causing depression 
and anxiety.
Because of the rarity of erythromelalgia, very little 
is known about how to effectively treat it(4). Current 
treatment does not address the cause of the condition, 
but involves high-dose oral medications to control 
pain and symptoms related to pain(5). Other options 
for partial relief from the symptoms of erythromelal-
gia include direct cooling and elevation of the affected 
limb or limbs(6).
Chronic stress can exacerbate the pathological 
consequences of erythromelalgia, resulting in physi-
ological or psychological dysfunction. Therapeutic 
techniques that reduce the consequences of stress—
for example, massage therapy (MT)—are therefore 
beneficial tools for improving overall health(7). Sleep 
disturbances are a major factor in many chronic pain 
syndromes, such as that with erythromelalgia. Thera-
peutic massage may support restorative sleep so that 
an optimal environment for healing and restoration 
may occur in the body. We believe this is the first case 
report about the use of MT as a treatment method for 
erythromelalgia.
Here, we present the case of a 31-year-old woman 
with erythromelalgia who was prescribed MT by 
her physician to manage her pain symptoms. MT 
treatments for this patient focused on reducing the 
severity of symptoms and side effects, on improving 
restorative sleep patterns, and on reducing stress and 
anxiety. It was hoped that, with MT, the patient would 
be able to resume activities of daily living. It was also 6
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hoped that, with the use of educational materials, 




The patient in this case was diagnosed in 2005 with 
idiopathic-onset erythromelalgia. Her medical history 
included fibromyalgia, Raynaud phenomenon, and 
Henoch–Schönlein purpura. A family history showed 
symptoms associated with erythromelalgia, such as 
occasional redness and heat in the distal extremities. 
This patient had participated in a variety of indoor and 
outdoor physical activities before onset of her symp-
toms. She had held a full-time job, but at the time of 
treatment, was receiving disability benefits because 
the pain limited her ability to work. The patient had 
never previously experienced massage or any other 
complementary therapy.
Assessment
The initial MT assessment showed limited ac-
tive and passive range of motion of the extremities 
because of hypertonicity in the muscles. The patient 
monitored her pain and discomfort using a pain scale 
of 0 – 10 (0 = no pain, 10 = extreme pain)(8). On ini-
tial assessment, the patient reported pain in the distal 
extremities as 8 bilaterally. She indicated experiencing 
more pain in the evening, peaking at night before bed, 
and she described experiencing painful symptoms of 
erythromelalgia approximately 3 – 4 days each week, 
with episodes lasting between 24 and 72 hours. She 
described the characteristics of the pain in the lower 
extremities as a cramping pressure, and she provided 
a photograph of the distal extremities showing redness 
and swelling as a result of erythromelalgia (Figure 1). 
Aggravating factors for the patient included extreme 
heat, extreme cold, exercise, or standing for longer than 
20 minutes, because gravity perpetuated swelling in the 
lower limbs. Elevation of the lower extremities would 
relieve swelling, but fail to alleviate pain. Signs and 
symptoms associated with the onset of erythromelalgia 
episodes included tension headaches, irregular periods, 
a decrease in restorative sleep because of pain, and ir-
ritable bowel syndrome, which the patient attributed 
to her medications. Daily medications prescribed by 
her primary care physician included oxycodone with 
acetaminophen as needed for management of the pain 
of fibromyalgia and erythromelalgia, and lorazepam 
and amitriptyline for depression and anxiety. The pa-
tient also took raberprazole, a proton-pump inhibitor, 
and senna glycosides, a mild laxative, to assist with 
bowel movements.
Contraindications to MT for a patient with eryth-
romelalgia would include any technique or modality 
that would aggravate the peripheral arteries (and there-
fore exacerbate symptoms). These contraindications 
include local techniques during extreme symptoms 
of erythromelalgia, broad stroking techniques to the 
lower extremities at any time, and heat applications to 
the lower extremities. Additional contraindications to 
MT are fever or signs and symptoms of a kidney infec-
tion (secondary to the Henoch-Schönlein purpura).
Having given informed consent to MT treatment, 
the patient took the positive outlook that MT would 
be beneficial for her conditions of stress and anxiety 
and might improve the erythromelalgia symptoms.
Treatment Overview
The patient received 9 treatments 7 – 14 days apart, 
each treatment lasting for 1 hour. The long-term goals 
of MT were to reduce the severity of erythromelalgia 
symptoms in the lower extremities, reduce pain, in-
crease relaxation, improve circulatory flow, improve 
restorative sleep, and enhance quality of life.
Treatments began with static contact and super-
ficial effleurage. Static contact is the least mechani-
cally stimulating of massage techniques; it is used to 
increase sedation and decrease anxiety(9). Superficial 
effleurage is a light, flowing technique that can be 
used to facilitate the flow of interventions and to 
achieve circulatory effects, psychological effects, and 
a variety of physiological effects.
For subsequent treatments, broad-contact compres-
sion was introduced. Broad-contact compression is a 
non-gliding technique that is delivered with a broad-
contact surface. It is a useful introductory stroke that 
can positively affect circulation(9).
Passive range of motion and passive stretch, as-
sisted by the massage therapist, were also introduced 
to all of the extremities. The patient was encouraged 
to continue passive stretching at home in an effort to 
improve flexibility and range of motion.
To reduce swelling and pain, superficial lymph 
drainage was introduced. The proposed mechanism 
fI g u r e  1.  Redness and swelling in the lower extremities of our 
patient with erythromelalgia.7
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for superficial lymph drainage is slow, delicate, 
rhythmical stretching of the tissues, which stimulates 
contraction of the lymphatic vessels, propels lymph 
through the collapsible superficial lymphatic system, 
increases local blood flow, and reduces the time re-
quired for alternative pathways (that is, anastomoses) 
to form after lymphatic pathways have been inter-
rupted by damage. When this technique is skillfully 
performed, it can result in sedation (parasympathetic 
activity), reduced pain (counterirritant analgesia), and 
improved general immune function(9). The patient 
was also encouraged to keep her legs elevated when 
possible at home so as to reduce swelling.
Each technique was introduced on a separate treat-
ment day for accurate feedback of its effect.
RESULTS
Over the course of 9 treatments, pain and discom-
fort were assessed using the 0 – 10 pain scale before 
and after treatment (Figure 2). For the purposes of 
this case report, activities of daily living, anxiety, and 
sleep (Table 1) were recorded as either improved or 
unchanged as a result of the MT treatments. Activities 
of daily living were measured by patient reports of her 
willingness to participate in certain tasks during her 
day, both inside and outside the home, and for how 
long she was able to tolerate the activity before de-
bilitating symptoms occurred. Anxiety was measured 
by patient feedback about how she was coping with 
the daily change of symptoms. Sleep was measured 
by the number of hours the client slept each night, the 
quality of the sleep, and whether painful symptoms 
were present.
After the first week of massage treatment, the pa-
tient chose to reduce her prescribed pain medication. 
The patient rated her physical pain and discomforts 
at 5 after the initial MT treatment, and averaged 6 on 
the pain scale over the course of 9 treatments (Fig-
ure 2). After the first treatment, the patient reported 
a decrease in her anxiety. The patient’s anxiety was 
relieved after 6 of 9 treatments. The patient noticed 
an improvement in the quality of her sleep, and she 
slept for longer periods throughout the night after 5 
of the 9 treatments. After 3 of the 9 treatments, the 
patient reported a willingness to participate in more 
activities of daily living (Table 1).
Overall, the results of the treatment plan show that 
the patient responded best to relaxation techniques 
(such as superficial effleurage) to the upper body and 
upper extremities after approximately 3 treatments. 
Superficial lymph drainage seemed to exacerbate the 
pain symptoms. The patient states that, since the start of 
the massage treatments, episodes of pain occur, but they 
have declined in frequency, duration, and intensity.
DISCUSSION
The goal in this case was to introduce MT tech-
niques as a method of pain management for symptoms 
of erythromelalgia. For many patients with eryth-
romelalgia, multiple pain medications are ineffective 
in achieving complete relief of pain symptoms(10). 
Physicians commonly treat chronic pain syndromes 
with medications for symptomatic relief. Patents 
with chronic pain may seek alternative therapies to 
reduce pain and to increase the ability to carry out 
everyday activities. A few studies have assessed non-
pharmacologic treatments that are used and preferred 
by patients with pain, concluding that massage and 
heat were the non-pharmacological treatments that 
resulted in the best pain alleviation(11). Compared 
with other healing modalities such as prescription 
drug programs, MT also boasts fewer, if any, nega-
tive side effects.
A review of the literature showed no other studies 
of MT treatment for erythromelalgia. However, in 
reports on chronic disease, rhythmical MT showed 
long-term reduction of chronic pain symptoms and 
an improvement in quality of life(12).
fI g u r e  2.  Changes in pain level. This chart illustrates the pain scale 
(0 – 10 on the vertical axis): 0 = no physical pain; 10 = extreme 
physical pain. The patient was asked to use the pain scale to rate 
her pain and discomfort before and after treatment (1 – 9 on the 
horizontal axis).
Ta b l e  1.  Pattern of Patient-Reported Improvements in Activities 
of Daily Living, Anxiety, and Sleep Across 9 Sessions of Massage 
Therapya
1 2 3 4 5 6 7 8 9
Activities of daily living + + +
Anxiety + + + + + +
Sleep + + + + +
a Plus signs indicate improvement, and blank cells indicate no 
change; the patient reported no decrements.8
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effleurage, and petrissage) applied to the whole 
body, especially the lower extremities. Lymphatic 
massage is also an important technique to use, with 
absolute knowledge of its execution so that it can 
be used at every visit depending on patient comfort 
and compliance.
We have several other recommendations for MT 
treatment plans designed to manage pain symptoms. 
It is important that the patient and the massage thera-
pist have a trusting and professional relationship. The 
patient must understand that, based on this treatment 
protocol, he or she may experience side effects related 
to treatment techniques before experiencing benefits. 
Positive effects from each massage treatment may be 
temporary, but can have a lasting effect over several 
treatments. Therefore, patient compliance is impor-
tant, and MT treatments must be regularly scheduled 
at the discretion of the therapist. For the patient to 
achieve long-term benefit, the patient and therapist 
must both be committed to regular treatments. A 
general recommendation is 2 treatment sessions per 
week, for approximately 3 weeks, with 48 hours 
between treatments. Patient feedback is encouraged 
before, during, and after treatment, so as to determine 
which techniques are helpful and which techniques 
seem to have no benefit for the patient. In addition, 
home care is strongly encouraged so that the patient 
can experience the benefits of treatment for a longer 
period of time. The introduction of one technique at a 
time into each treatment is important for recognizing 
the techniques that are helping the condition and those 
that may be making the condition worse.
Future studies should include a larger sample size. 
For more accurate assessments, future studies should 
use multiple pain assessments. Examples include self-
reports, behavioral assessments, and physiological 
measures such as the McGill Pain Questionnaire, a 
visual analog scale (VAS), or the Multidimensional 
Pain Inventory. If depression or anxiety is present, 
the Beck Depression Inventory and the Spielberger 
State–Trait Anxiety Inventory may be used. Use of 
these assessments will more accurately represent the 
results of the treatment plan, helping the therapist and 
the patient to monitor progress.
Based on the treatment protocol presented here, 
MT may provide an increased state of relaxation, 
decreased anxiety, decreased muscle tension, and 
improved sleep in a patient with erythromelalgia. 
These indirect positive effects may have a role in the 
patient’s ability to cope day to day with symptoms. 
This treatment plan and the associated guidelines 
can contribute to further studies of erythromelalgia 
patients seeking alternative therapies.
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Our results reveal that relaxation massage tech-
niques, such as superficial effleurage to the upper 
body and extremities, provided restorative sleep and 
helped to reduce anxiety for the patient. The patient 
was able to relax, to achieve more restorative sleep, 
and to enjoy a longer period of time between severe 
symptoms. She reported that massage helped to pro-
vide relief between severe episodes of erythromelal-
gia and that it improved her quality of life. Massage 
techniques applied directly to the lower extremities 
caused anxiety for the patient. Superficial lymphatic 
techniques seemed to provide temporary relief for the 
patient during treatment, but lasted for only a short 
time once she was standing.
Further studies about the use of MT in the treat-
ment of erythromelalgia are required. Treatments 
provided more frequently may amplify the positive 
results observed in the present study. Patients must be 
individually treated because each patient experiences 
various degrees of discomfort caused by erythromela-
lgia. We feel that the introduction of superficial lymph 
techniques earlier in the treatment sequence should 
further reduce the painful symptoms of erythromela-
lgia. In patients that are willing to attend treatments 
on a more regular schedule, evidence might be ob-
tained of a beneficial effect of MT on their condition 
during acute symptomatic episodes. Despite having 
additional health complications such as fibromyalgia, 
Raynaud phenomenon, and Henoch-Schönlein pur-
pura, our patient noted a positive influence of MT on 
her pain management.
Because this report concerns just a single patient, it 
is important to recognize that the approach described 
is not a generalized treatment for all erythromelalgia 
cases. Special considerations in this particular treat-
ment plan dealt with the effects that MT could have on 
symptoms of erythromelalgia, while taking account 
of how MT techniques might affect the other condi-
tions present (Raynaud phenomenon, fibromyalgia). 
Raynaud phenomenon has a presentation similar 
to that of erythromelalgia: both deal with radical 
responses in the extremities and peripheral arteries 
to a change in temperature. The patient in this case 
report had been diagnosed with secondary Raynaud 
phenomenon, which occurs as a complication from 
an underlying problem. The clinical manifestation of 
Raynaud phenomenon may be the final expression 
of abnormal reactivity of the terminal arteries(13,14). 
During local or whole-body cooling, blood flow to 
the skin is reduced to prevent heat loss. This response 
to cold is mediated by reflex activation of the sympa-
thetic nervous system and by a direct effect of cold 
on cutaneous blood vessels(15).
The patient expressed anxiety about techniques 
that might aggravate her symptoms. Often, this 
anxiety would prevent the therapist from working 
locally on the lower extremities. A generalized MT 
treatment plan for erythromelalgia is recommended 
to include relaxation techniques (static contact, gentle 9
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